294 related articles for article (PubMed ID: 24709902)
21. miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.
Shan X; Wen W; Zhu D; Yan T; Cheng W; Huang Z; Zhang L; Zhang H; Wang T; Zhu W; Zhu Y; Zhu J
PLoS One; 2017; 12(1):e0170298. PubMed ID: 28099468
[TBL] [Abstract][Full Text] [Related]
22. Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells.
Seton-Rogers SE; Lu Y; Hines LM; Koundinya M; LaBaer J; Muthuswamy SK; Brugge JS
Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1257-62. PubMed ID: 14739340
[TBL] [Abstract][Full Text] [Related]
23. Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis.
Deng X; Li Q; Hoff J; Novak M; Yang H; Jin H; Erfani SF; Sharma C; Zhou P; Rabinovitz I; Sonnenberg A; Yi Y; Zhou P; Stipp CS; Kaetzel DM; Hemler ME; Yang XH
Neoplasia; 2012 Aug; 14(8):678-89. PubMed ID: 22952421
[TBL] [Abstract][Full Text] [Related]
24. Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation.
Yu M; Lin G; Arshadi N; Kalatskaya I; Xue B; Haider S; Nguyen F; Boutros PC; Elson A; Muthuswamy LB; Tonks NK; Muthuswamy SK
Mol Cell Biol; 2012 Oct; 32(19):3913-24. PubMed ID: 22851698
[TBL] [Abstract][Full Text] [Related]
25. Characterisation of tumoral markers correlated with ErbB2 (HER2/Neu) overexpression and metastasis in breast cancer.
Durán MC; Vega F; Moreno-Bueno G; Artiga MJ; Sanchez L; Palacios J; Ridley A; Timms JF
Proteomics Clin Appl; 2008 Sep; 2(9):1313-26. PubMed ID: 21136925
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells.
Lu Y; Zi X; Zhao Y; Pollak M
Biochem Biophys Res Commun; 2004 Jan; 313(3):709-15. PubMed ID: 14697248
[TBL] [Abstract][Full Text] [Related]
27. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
Yen L; Cao Z; Wu X; Ingalla ER; Baron C; Young LJ; Gregg JP; Cardiff RD; Borowsky AD; Sweeney C; Carraway KL
Cancer Res; 2006 Dec; 66(23):11279-86. PubMed ID: 17145873
[TBL] [Abstract][Full Text] [Related]
28. Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.
Xu FJ; Stack S; Boyer C; O'Briant K; Whitaker R; Mills GB; Yu YH; Bast RC
Clin Cancer Res; 1997 Sep; 3(9):1629-34. PubMed ID: 9815853
[TBL] [Abstract][Full Text] [Related]
29. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.
Klos KS; Wyszomierski SL; Sun M; Tan M; Zhou X; Li P; Yang W; Yin G; Hittelman WN; Yu D
Cancer Res; 2006 Feb; 66(4):2028-37. PubMed ID: 16489002
[TBL] [Abstract][Full Text] [Related]
30. Protein-tyrosine phosphatase PTPN9 negatively regulates ErbB2 and epidermal growth factor receptor signaling in breast cancer cells.
Yuan T; Wang Y; Zhao ZJ; Gu H
J Biol Chem; 2010 May; 285(20):14861-14870. PubMed ID: 20335174
[TBL] [Abstract][Full Text] [Related]
31. p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1.
Tornillo G; Bisaro B; Camacho-Leal Mdel P; Galiè M; Provero P; Di Stefano P; Turco E; Defilippi P; Cabodi S
Eur J Cell Biol; 2011; 90(2-3):237-48. PubMed ID: 20961652
[TBL] [Abstract][Full Text] [Related]
32. DEPTOR stabilizes ErbB2 to promote the proliferation and survival of ErbB2-positive breast cancer cells.
Bi Y; Chen X; Wei B; Wang L; Gong L; Li H; Xiong X; Zhao Y
Theranostics; 2021; 11(13):6355-6369. PubMed ID: 33995662
[No Abstract] [Full Text] [Related]
33. Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis.
Gillibert-Duplantier J; Duthey B; Sisirak V; Salaün D; Gargi T; Trédan O; Finetti P; Bertucci F; Birnbaum D; Bendriss-Vermare N; Badache A
Oncogene; 2012 Jul; 31(30):3516-24. PubMed ID: 22105364
[TBL] [Abstract][Full Text] [Related]
34. Resistance to ErbB2 tyrosine kinase inhibitors in breast cancer is mediated by calcium-dependent activation of RelA.
Xia W; Bacus S; Husain I; Liu L; Zhao S; Liu Z; Moseley MA; Thompson JW; Chen FL; Koch KM; Spector NL
Mol Cancer Ther; 2010 Feb; 9(2):292-9. PubMed ID: 20124457
[TBL] [Abstract][Full Text] [Related]
35. Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion.
Sciortino M; Camacho-Leal MDP; Orso F; Grassi E; Costamagna A; Provero P; Tam W; Turco E; Defilippi P; Taverna D; Cabodi S
Sci Rep; 2017 Apr; 7(1):1145. PubMed ID: 28442738
[TBL] [Abstract][Full Text] [Related]
36. Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells.
Canfield K; Li J; Wilkins OM; Morrison MM; Ung M; Wells W; Williams CR; Liby KT; Vullhorst D; Buonanno A; Hu H; Schiff R; Cook RS; Kurokawa M
Cell Cycle; 2015; 14(4):648-55. PubMed ID: 25590338
[TBL] [Abstract][Full Text] [Related]
37. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
38. ErbB2 Is Necessary for ErbB4 Ligands to Stimulate Oncogenic Activities in Models of Human Breast Cancer.
Mill CP; Zordan MD; Rothenberg SM; Settleman J; Leary JF; Riese DJ
Genes Cancer; 2011 Aug; 2(8):792-804. PubMed ID: 22393464
[TBL] [Abstract][Full Text] [Related]
39. Erb-b2 Receptor Tyrosine Kinase 2 (ERBB2) Promotes ATG12-Dependent Autophagy Contributing to Treatment Resistance of Breast Cancer Cells.
Chen Y; Wang R; Huang S; Henson ES; Bi J; Gibson SB
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33801244
[TBL] [Abstract][Full Text] [Related]
40. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.
Peng M; Ball-Kell SM; Tyner AL
Cell Death Dis; 2015 Aug; 6(8):e1848. PubMed ID: 26247733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
